Chirag Lodha

A Review of the Current Literature Regarding Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Preserved Ejection Fraction and Timing of Initiating Therapy

Heart failure with preserved ejection fraction (HFpEF) is a growing public health burden that now accounts for nearly half of all HF diagnoses in the United States. Modern classifications of HF divide patients into HFpEF and HF with reduced ejection fraction (HFrEF). Historically, diagnosis has relied on the Framingham...